Targetrust Biotech. Ltd

Targeted drugs and chemotherapy drugs are common in cancer therapy. Drug resistances are often detected too late or misjudged and cause mortality with all current methods including CT scan, liquid biopsy, and traditional blood biomarkers such as CEA test. Our product blood p-CSE1L IVD kit directly assay tumor signal activity in blood; Clinical trials showed our product can early (2-weeks post-therapy) and real-time detect drug resistance in cancer therapy. The product helps patients get correct drug in time. It has the potential to be marketed to hospitals worldwide.